Effect of Ensifentrine on Sputum Markers of Inflammation in COPD

NCT05270525 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: Ensifentrine
DRUG: Placebo

Sponsor

Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Collaborators

[object Object]